High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
2022 · Breast Cancer Research · 45 citations
https://doi.org/10.1186/s13058-022-01563-7
H
Hiroko Onagi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
235
Citations
8
h-index
7
i10-index
Hiroko Onagi is an academic researcher from Juntendo University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & Breast Lesions and Carcinomas. The author has an h-index of 8, co-authored 30 publications.
Papers by this author
worksComparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
2021 · JTO Clinical and Research Reports · 24 citations
https://doi.org/10.1016/j.jtocrr.2021.100230
Comparison of <scp>ASCL1</scp>, <scp>NEUROD1</scp>, and <scp>POU2F3</scp> expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma
2023 · Histopathology · 18 citations
https://doi.org/10.1111/his.14872
Attempt to Substitute the Oncotype DX Breast Recurrence Score® Test by Histopathological Factors and MUC1 Protein Expression
2024 · Cancer Diagnosis & Prognosis · 5 citations
https://doi.org/10.21873/cdp.10349
HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)
2024 · Pathology International · 3 citations
https://doi.org/10.1111/pin.13404
Characterization of breast cancer tumors in older patients who show de novo resistance to endocrine therapy
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-83895-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat